Columbia Laboratories, Inc. Licenses STRIANT Canadian Trademark and Marketing Rights to Invaron Pharmaceuticals Inc.

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) has entered into a license agreement with Invaron Pharmaceuticals Inc. (“Invaron”), a privately-held Canadian pharmaceutical company, for STRIANT® (testosterone buccal system) in Canada.